Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07149740 · ClinicalTrials.gov registry record
Data Gathering for A10900
A clinical trial of Healthy and Glaucoma, sponsored by Optos.
- Recruiting
- Registry status
- 180
- Enrollment target
- 4
- Study locations
NCT07149740: Recruiting study of Healthy and Glaucoma, sponsored by Optos.
NCT07149740 is a study of Healthy and Glaucoma that is actively recruiting participants, run by Optos. The registered enrollment target is 180 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07149740, a study of Healthy and Glaucoma, is actively recruiting participants, sponsored by Optos.
- RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes
Conditions Studied
Interventions
- DEVICE OCT
Study Locations (4)
California
- Ketchum Health - Anaheim
Connecticut
- Eye Disease Consultants, LLC - West Hartford
Massachusetts
- Eye Care and Laser Surgery of Newton Wellselley - Wellesley Hills
Tennessee
- Charles Retina Institute - Germantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-06-26 |
| Est. Completion | 2026-05-01 |
What NCT07149740 shows while recruiting
NCT07149740 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (72% lower).
The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which OCT is the first listed.
NCT07149740 reports a single indexed study location in California, Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07149740 about?
NCT07149740 is a clinical study titled "Data Gathering for A10900". The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes
What is the current status of trial NCT07149740?
This trial is currently recruiting. The enrollment target is 180 participants. The study started on 2025-06-26. Estimated completion is 2026-05-01.
What conditions does trial NCT07149740 study?
This clinical trial studies the following conditions: Healthy, Glaucoma, Retinal Disease, Corneal Diseases.
What interventions are being tested in trial NCT07149740?
The interventions under investigation include: OCT (DEVICE).
Who is sponsoring clinical trial NCT07149740?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07149740 being conducted?
This trial has 4 study locations across California, Connecticut, Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07149740's enrollment target sits among peer trials
180 135th of 1090 higher than 953 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI